Prof. Dr. Evrim METCALFE

A. Articles published in international peer-reviewed journals after specialization:
A1. Gorken IB, Bayman E, Balci P, Bakis B, Karaguler Z, Isman BD, Kinay M. Comparing ultrasound with computerized tomography images to choose electron energy for radiotherapy boost field in breast cancer patients with breast conserving surgery. J BUON 2010; 15 (3): 500-503.
A2. Etiz D, Bayman E, Akcay M, Sahin B, Bal C. Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy. Asian Pac J Cancer Prev 2013; 14(7): 4223-4228.
A3. Etiz D, Ataizi FC, Bayman E, Akcay M, Acıkalın MF, Colak E, Ciftci E. Prognostic value of osteopontin in patients treated with primary radiotherapy for head and neck cancer. Asian Pac Cancer Prev 2013; 14(9): 5175-5178.
A4. Erpolat OP,Alco G,Caglar HB,Igdem S,Saran A,Dagoglu N,Aslay I,Ozsaran Z,Demirci S,Keven E,Guney Y,Akmansu M,Kilic D,Bayman E,Etiz D,Mandel NM. Comparisonofhematologictoxicitybetween3DCRTandIMRTplanningincervicalcancerpatientsafter concurrentchemoradiotherapy: anationalmulti-centerstudy. Eur J Gynaecol Oncol2014; 35(1):62-6.
A5. Bayman E, Prestwich RJ, Speight R, Aspin L, Garratt L, Wilson S, Dyker KE, Sen M. Patterns of Failure after Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol) 2014; 26(10): 636-42.
A6. Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev 2014; 15(15): 6264-7.
A7. Murray L, Sethugavas B, Robertshaw H, Bayman E, Thomas E, Gilson D, Prestwich RJ. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol)2015;27(7):401-10.
A8. Bird D, Scarsbrook AF, Sykes J, Ramasamy S, Subesinghe M, Carey B, Wilson DJ, Roberts N, McDermott G, Karakaya E, Bayman E, Sen M, Speight R, Prestwich RJ. Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma. BMC Cancer2015; 15:844.
A9. Metcalfe E,Etiz D. Early transient radiation-induced brachial plexopathy in locally advanced head and neck cancer. Contemp Oncol (Pozn)2016; 20(1):67-72.
A10. Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma. Contemp Oncol (Pozn)2016; 20(3): 251-5.
A11. Metcalfe E, Aspin L, Speight R, Hermit E, Ramasamy S, Cardale K, Dyker KE, Sen M, PrestwichRJ. Postoperative (Chemo)Radiotherapy for Oral Cavity Squamous Cell Carcinomas: Outcomes and Patterns of Failure. Clin Oncol (R Coll Radiol)2017; 29(1): 51-59.
A12. Etiz D, Metcalfe E, Akcay M. Multiple primary malignant neoplasms: A 10-year experience at a single institution from Turkey. J Cancer Res Ther2017; 13(1):16-20.
A13. Metcalfe E,Arik D,Oge T,Etiz D,Yalcin OT,Kabukcuoglu S,Pasaoglu O,Ozalp SS. CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy. J Cancer Res Ther 2018; 14(6): 1373-1378.
A14. Oktay E, Levent M, Gelincik H, Aktaş G, Yumuk F, Koral L, Arpaci E, Keser M, Alkan A, Karci E, Karadurmuş N, Degirmencioglu S, Turan M, Uyeturk U, Cabuk D, Avci N, Toprak O ,Ergen A,Urvay S,BaymanE,Petekkaya E,Nayir E,Stakeholder S,Yavuzsen T,Senler FC,Yaren A,Barutca S,Sahinler İ,Ozyilkan O,TanriverdiO. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ2020; 35(1):69-75.
B. Papers presented at international scientific meetings after specialization and published in proceedings books:
B1. Gorken IB, Bayman E, Balci P, Bakis B, Kocdor MA, Karaguler Z, Isman BD, Cetinayak O, Alanyali H, Kinay M. Comparing ultrasound (US) with computerized tomography (CT) images to choose electron energy for boost field in breast cancer patients with breast-conserving surgery (Verbal). 6th Congress BUON, Sofia, Bulgaria, September 13-16, 2006.
B2. Bayman E, Ataman OU, Akman F, Kinay M. Evaluation of set-up errors using electronic portal imaging in head and neck carcinoma (Poster). International Meeting on Innovative Approaches in Head and Neck Oncology, Barcelona, ​​Spain, February 22-24, 2007.
B3. Bicakci N, Bayman E. PET-CT negative osteoblastic bone metastasis progression in a follow-up patient with a diagnosis of metastatic breast cancer: A Case Report (Poster). 9th International Nuclear Oncology Congress & 22nd National Nuclear Medicine Congress, 25-29 April 2010, Antalya.
B4. Erpolat OP,Alco G,Igdem S, Dagoglu N,Aslay I,Ozsaran Z,Demirci S,Keven E,Guney Y,Akmansu M,Kilic D,Bayman E,Etiz D,Mandel NM. Dosimetric Parameters Of Acute Hematologic Toxicity In Cervical Cancer Patients Treated With Concurrent Cisplatin And Pelvic Radiotherapy: Turkish Oncology Group Gynecological Tumor Subgroup Study (Poster). ASTRO’s 54th Annual Meeting, October 28 – 31, 2012, Boston, USA.
B5. Bayman E, Prestwich R, Aspin L, Garratt L, Wilson S, Speight R, Dyker K, Coyle C, Sen M. Pattern of failure after intensity modulated radiation therapy for head anc neck squamous cell carcinoma (Poster). International Journal of Radiation Oncology Biology Physics: 87(2S):469; ASTRO’s 55th Annual Meeting September 22 – 24, 2013, Atlanta, USA.
B6. Turgut Cosan D, Soyocak A, Oner C, Erkasap MS, Bayman E, Mutlu Sahin F, Djamgoz MBA. The importance of voltage gated channels in breast cancer (Poster). 5th International Congress on Cell Membranes and Oxidative Stress: Focus on Calcium Signaling and TRP Channels, 9-12 September 2014, Isparta, Turkey.
B7. Ergen SA, Dincbas HF, Metcalfe E, Akyurek S, Yavas G, Ulger S, Ozdemir BS, Yucel B, Oksuz DC, Senocak M, Bozcuk H. Patterns of Failure and the Prognostic Factors of the Patients with LD SCLC according to the TNM staging; TOG-TROD Study (Poster). IASLC 17th World Conference on Lung Cancer, December 4-7, 2016, Vienna, Austria.
B8. Calis IU, Metcalfe E, Cosan DT. Serum S1P levels in breast cancer development (Oral). 3rd International Congress on Applied Biological Sciences, 09-12 July 2017, Konya, Turkey.
B9. Kosgeroglu N, Kersu O, Metcalfe E. Evaluation of mostmastectomy patient’s adaptation to cure and care according to Roy adaptation model (Oral). 13th International Conference on Social Sciences, 6-7 October 2017, Vienna, Austria.
B10. Altinok A, Gursel B, Ergen A, Alanyali S, Ozsaran Z, Ay A, Metcalfe E, Akmansu M, Tepetam H, Altinok P, Altmisdortoglu O, Serarslan A, Bese N. Postmastectomy RT Decision for Lymph Node Negative patients: Turkish Radiation Oncology Society (Poster). ESTRO 37, 20-24 April 2018, Barcelona, ​​Spain.
B11. Metcalfe E, Yazici O, Korkmaz Kirakli E, Altinok A, Aytac Arslan S, Ibrahimov R, Altinok P. Adjuvant therapy in patients older than 70 ys with head and neck cancer (HNC): Turkish HNC Group study (Poster). 7th ICHNO International Congress on Innovative Approaches in Head and Neck Oncology, 14-16 March 2019, Barcelona, ​​Spain (proceeding Radiotherapy & Oncology 2019; 132 (supp 1): 92-93).
B12. Metcalfe E, Akagunduz O, Aynaci O, Kaydihan N, Aslan SA, Kirakli E, Altinok A, Saginc H, Altinok P, Yazici O. Adjuvant radiotherapy outcomes in aged 70 and older patients with head and neck carcinoma: Multi-institutional study of TOG head and neck cancers group (Poster).19th Conference of the International Society of Geriatric Oncology, 14-16 November 2019, Geneva, Switzerland.
C. Chapters in national/international books:
C1. Malignant Pleural Mesothelioma Türkiye Standards Guide, Malignant Pleural Mesothelioma
Radiotherapy in the Treatment (Panel), ISBN 978-605-9975-00-1, 2014.
C2. Cancer 10th Edition Turkish translation, translation editors Assoc. Dr. Ahmet Alacacioglu, Prof. Dr. Mehmet Ali Ozcan. Pediatric cancers section translation, 2019.
C3. Türkiye Clinics Special Issue, Geriatric Radiotherapy, 2021.
C4. Turkiye Klinikleri Special Issue, Geriatric Patients and Ethics in Radiation Oncology, 2022.
D. Articles published in national peer-reviewed journals after specialization:
D1. AN Demiral, M. Şen, O. Çetinayak, E. Bayman, H. Havıtçıoğlu, M. Manisalı, S. Özkal, İ. Öztop, F. Akman, M. Kinay. Treatment results and prognostic factors in post-operative radiotherapy-treated soft tissue sarcomas. Turkish Journal of Oncology 2006; 21(3): 119-124.
D2. I. B. Görken, E. Bayman, S. Bora, İ. Oztop, U. Yilmaz, H. Alanyali, M. Kinay. Concomitant chemoradiotherapy application after surgery in gastric carcinomas in outpatient clinic conditions (Protocol preliminary results). Turkish Journal of Oncology 2006; 21(4): 178-184.
D3. E. Bayman, O.U. Ataman, M. Kinay, F. Akman. How to determine margins for planning target volume (PTV): from 2D to 3D planning in radiotherapy for head and neck cancer? Portal imaging assessment for set-up errors. Turkish Journal of Oncology 2010; 25(3): 104-110.
D4. N. Bıçakcı, FC Tosun, T. Başoğlu, E. Bayman. False-Negative F-18 FDG PET Findings in Progressive Osteoblastic Metastases of Breast Cancer. Case Report. Turk J Nucl Med 2010; 19(3): 148-53.
D5. D. Etiz, E. Bayman. Fatal hematologic toxicity due to temozolomide administered during glioblastoma multiforme radiotherapy: a case report. Osmangazi Medical Journal 2011; 33(2): 56-59.
D6. D. Etiz, E. Bayman, Bilgehan Sahin. Second series radiotherapy in a case of recurrent locally advanced basal cell carcinoma (BCC): a case report. Osmangazi Medical Journal 2011; 33(3):5-8.
D7. D. Etiz, E. Bayman. Role of radiotherapy in rectal cancer. Osmangazi Medical Journal 2012; 34(2):11-19.
D8. E. Bayman, N. Bıçakcı, EK Gülen. Hyperbaric oxygen experience in bisphosphonate-induced osteonecrosis of the jaw: a case report with metastatic breast cancer. Osmangazi Medical Journal 2013; 35(3): 1-5.
D9. M. Akçay, A. Özen, S. Uslu, H. Yıldırım, E. Metcalfe, D. Etiz. Factors Affecting the Development of Radiation Pneumonia in Patients with Lung Cancer Diagnosed with Radiotherapy. Osmangazi Medical Journal 2017; 39(3): 35-43.
D10. DT Cosan, C. Öner, A. Soyocak, E. Metcalfe, M. Djamgoz. The role of inhibition of Kv 1.3 and Kv 10.1 voltage-dependent potassium channels on oxidative stress in breast cancer. Dicle Medical Journal 2017; 44(1):43-50.
D11. A. Ozkaraman, E. Metcalfe, O. Kersu, E. Ozturk, N. Kosgeroglu, E. Colak. The Effect of Light on Quality of Sleep and Life in Breast Cancer Patients. Journal of Turkish Sleep Medicine 2018; 5(1): 17-23.
D12. Altinok A, Gursel B, Ergen A, Alanyali S, Ozsaran Z, Ay A, Metcalfe E, Akmansu M, Tepetam H, Altinok P, Altmisdortoglu O, Serarslan A, Bese N. Postmastectomy Radiotherapy Decision for Patients
without Lymph Node Metastases: Turkish Radiation Oncology Society Breast Cancer Working Group. Turk J Oncol 2019; 34(3): 168–73.
D13. H. Demir, BC Bıçakcı, F. Demircioğlu, D. Yavuzer, G. Yaprak, E. Metcalfe. Glioblastoma with Extracranial Multiple Metastasis. Turk J Oncol 2022;37(1):102–104.
E. Papers presented at national scientific meetings after specialization and published in proceedings books:
E1. İ.B. Görken, E. Bayman, BD Isman, G. Arslan, H. Alanyalı, M. Kinay. Our Adjuvant Radiotherapy Results in Operated Seminomatous Testicular Tumors (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E2. F. Akman, O.U. Ataman, E. Bayman, BD İşman, C. Ecevit, S. Sarıoğlu, E. Ada, M. Şen, M. Kınay. Treatment Approach and Results in Head and Neck Localized Neck Masses of Unknown Primary (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E3. İ.B. Görken, T. Canda, E. Bayman, S. Saydam, B. Demirkan, P. Balcı, BD İşman, H. Alanyalı, Ö. Harmancioglu, M. Kinay. Application of St Gallen-05 prognostic factors to our patients without axillary involvement (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E4. E. Bayman, İ.B. Görken, P. Balcı, B. View, MA Koçdor, Z. Karagüler, BD İşman, O. Çetinayak, H. Alanyalı, M. Kınay. Comparison of ultrasound (USG) and computed tomography (CT) in the selection of “boost” area electron energy in radiotherapy (RT) of breast cancer patients who underwent Breast Conserving Surgery (BCT) (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E5. İ.B. Görken, H. Alanyalı, E. Bayman, A. Demiral, M. Koyuncuoğlu, Z. Arıcan, F. Obuz, B. Demirkan, M. Kınay. Treatment results and prognostic factors in patients with cervical cancer who underwent radical radiotherapy (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E6. İ.B. Görken, E. Bayman, S. Bora, İ. Oztop, U. Yilmaz, H. Alanyali, M. Kinay. Postoperative simultaneous chemoradiotherapy application in gastric carcinomas in polyclinic conditions – Protocol preliminary results (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E7. F. Akman, O.U. Ataman, E. Bayman, C. Ecevit, BD Isman, S. Sarioglu, E. Ada, M. Kinay. Local Evaluation of our radical radiotherapy results and prognostic factors in patients with advanced hypopharyngeal cancer (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E8. F. Akman, E. Bayman, O.U. Ataman, B. Isman, C. Ecevit, A.O. İkiz, M. Şen, M. Kinay. Applicability of radical radiotherapy with concurrent chemotherapy in patients with non-nasopharyngeal head and neck cancer (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E9. O.U. Ataman, F. Akman, B. Isman, E. Bayman, C. Ecevit, A. Ö. İkiz, M. Kinay. Evaluation of the feasibility of postoperative chemoradiotherapy in patients with head and neck cancer (Poster). VII. National Radiation Oncology Congress, 19-23 April 2006, Ölüdeniz, Fethiye.
E10. N. Bicakci, E. Bayman. PET-CT negative osteoblastic bone metastasis in a follow-up patient with a diagnosis of metastatic breast cancer: A Case Report (Poster). X. National Breast Diseases Congress, 30 September-4 October 2009, Çeşme, İzmir.
E11. E. Bayman, N. Bıçakcı, C. Yüksel. Breast carcinoma detected in response evaluation with PET-CT in a patient who underwent chemotherapy with the diagnosis of lung adenocarcinoma: A case report whose primary was discussed (Poster). X. National Breast Diseases Congress, 30 September-4 October 2009, Çeşme, İzmir.
E12. N. Bıçakcı, E. Bayman, S. Albayrak. Our PET-CT experience in our patients with breast cancer during the transition period from Service Hospital to Education-Research Hospital: Results of the first evaluation (Poster). X. National Breast Diseases Congress, 30 September-4 October 2009, Çeşme, İzmir.
E13. E. Bayman, N. Bicakci. PET-CT experience in post-treatment prognosis evaluation in urological cancers: Our first results (Poster). 9th Urooncology Congress, 4-8 November 2009, Ankara.
E14. N. Bicakci, E. Bayman. Detection of metastatic focus in the breast on PET-CT in a patient followed up with a diagnosis of renal cell cancer: A rare case report (Poster). 9th Urooncology Congress, 4-8 November 2009, Ankara.
E15. E. Bayman, A. Aykin. Mandibular osteonecrosis due to intravenous (IV) bisphosphonate use: A case report with metastatic breast cancer (Report). 9th National Radiation Oncology Congress, 21-25 April 2010, Girne, Turkish Republic of Northern Cyprus.
E16. D. Etiz, E. Bayman, M. Yakar. Our Treatment Outcomes and Evaluation of Prognostic Factors in Inoperable Pancreatic Carcinoma (Poster). 19th National Cancer Congress, 20-24 April 2011, Antalya
E17. D. Etiz, M. Akçay, C. Bal, E. Bayman. Gastric Carcinoma Cases Received Adjuvant Radiotherapy: Eskişehir Osmangazi University Experience (Poster). 19th National Cancer Congress, 20-24 April 2011, Antalya
E18. E. Bayman, D. Etiz, G. Ak, Z. Dalar, E. Tekçe. Our Treatment Outcomes and Evaluation of Prognostic Factors in Limited Stage Small Cell Lung Carcinoma (Poster). 19th National Cancer Congress, 20-24 April 2011, Antalya.
E19. F. Canaz, E. Çiftçi, MK Gürbüz, MF Açıkalın, E. Bayman. Primary Mucosal Malignant Melanoma of the Head and Neck Region (Poster). 21st National Pathology Congress, 16-20 November 2011, İzmir.
E20. Erpolat PÖ, Alço G, İğdem Ş, Dağoğlu N, Aslay I, Özsaran Z, Demirci S, Keven E, Güney Y, Akmansu .m, Kılıç D, Bayman E, Etiz D, Mandel NM. Determination of Dosimetric Parameters Causing Hematological Toxicity in Patients with Cervical Cancer treated with Concurrent Cisplatin and Pelvic Radiotherapy: Turkish Oncology Group Gynecological Tumors Subgroup Study. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E21. Gürbüz MK, Özüdogru EN, Etiz D, Açıkalın MF, Çiftçi E, Bayman E, Canaz F, Kaya E, Abakay MA, Akçay MC, Çolak E. Nuclear factor kappa-B and hypoxia-induced factor (HIF) in early stage glottic cancers The relationship of -1 alpha with radiosensitivity. 34. Turkish National Congress of Otorhinolaryngology and Head and Neck Surgery, 10-14 October 2012, Antalya.
E22. Etiz D, Bayman E, Private İ. Treatment Outcomes and Prognostic Factor Analysis in Female Patients with Lung Cancer: ESOGÜTF Radiation Oncology Clinical Experience. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E23. Bayman E, Etiz D, Şaylısoy S. Leptomeningeal and Intramedullary Involvement in Small Cell Lung Cancer: Rare Metastasis Localization and Two Case Reports. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E24. Bayman E, Akyazıcı E, Kurt M, Çolak E. Evaluation of Patients with Locally Advanced Stage Head and Neck Cancer who received Three-Dimensional Conformal Radiotherapy in terms of Acute Side Effects and Quality of Life with EORTC QLQ C30 and H&N35 Turkish Modules. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E25. Etiz D, Bayman E, Şaylısoy S, Akçay M. Dosimetric Analysis of Brachial Plexus in Patients with Locally Advanced Head and Neck Cancer Treated with Three-Dimensional Conformal Radiotherapy. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E26. Etiz D, Bayman E, Şahin B. 20 Our Primary Radiotherapy Results in Hypopharyngeal Cancer. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E27. Bayman E, Etiz D, Akçay M. Multiple Primary Malignancies as an Increasing Oncology Problem: Eskişehir Osmangazi University Oncology Center Experience. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E28. Etiz D, Bayman E, Şahin B, Private İ. Radiotherapy Experience in a Case of Locally Advanced Basal Cell Carcinoma: A Case Report. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E29. Etiz D, Bayman E, Yakar M. ESOGÜTF Radiation Oncology Experience: Analysis of Treatment Outcomes and Prognostic Factors in Inoperable Pancreatic Cancer. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E30. Etiz D, Bayman E, Akçay M. Primary Radiotherapy in Locally Advanced Cervical Cancer. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E31. Bayman E, Etiz D, Şahin B. ESOGÜTF Radiation Oncology Clinical Experience: Evaluation of Ten Cases with Vulvar Cancer. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E32. Etiz D, Bayman E, Dalar Z, Bal C. 28 Cases of Cervical Carcinoma Received Adjuvant Radiotherapy. 10. National Radiation Oncology Congress, 19-23 April 2012, Antalya.
E33. Bayman E, Prestwich R, Aspin L, L.Garratt, S.Wilson, R.Speight, K.Dyker, C.Coyle, M.Sen. Recurrence characteristics after adjuvant intensity modulated radiotherapy in head and neck squamous cell cancers (Poster). 20. National Cancer Congress, 19-23 April 2013, Antalya.
E34. Etiz D, Ataizi FÇ, Bayman E, Yakar MC, Açıkalın M, Canaz F, Çolak E. The prognostic importance of osteopontin, EGFR and VEGF in patients with squamous cell carcinoma of the head and neck treated with primary radiotherapy. 20. National Cancer Congress, 19-23 April 2013, Antalya.
E35. Tekçe E, Bayman E, Şahin B, Akçay M, Dalar Z, Coşan E, Etiz D. Evaluation of radiotherapy, concomitant temozolamide results and prognostic factors in patients with adult glioblastoma multiforme. 20. National Cancer Congress, 19-23 April 2013, Antalya.
E36. Entok E, Yıldız B, Etiz D, Sivrikoz IA, Bayman E, Üstün H. Oligodendroglioma with bone marrow metastases: evaluation with PET/CT. 20. National Cancer Congress, 19-23 April 2013, Antalya.
E37. Etiz D, Bayman E, Şahin B, Akçay M, Dalar Z. ESOGÜTF radiation oncology center: experience of 123 multiple primary cancer cases. 20. National Cancer Congress, 19-23 April 2013, Antalya.
E38. Bayman E, Etiz D, Şaylısoy S, Yakar M. Clinical and dosimetric evaluation of the relationship between brachial plexus doses and early plexopathy in locally advanced head and neck cancer radiotherapy. 20. National Cancer Congress, 19-23 April 2013, Antalya.
E39. Bayman E, Prestwich R, Aspin L, L.Garratt, S.Wilson, R.Speight, K.Dyker, C.Coyle, M.Sen. Recurrence characteristics after curative intensity modulated radiotherapy in head and neck squamous cell cancers (Verbal). 20. National Cancer Congress, 19-23 April 2013, Antalya.
E40. Bayman E, Arık D, Element T, Etiz D, Yalçın ÖT, Kabukçuoğlu S, Paşaoğlu Ö, Özalp S. Evaluation of CD105 (Endoglin) expression as an angiogenesis marker in patients who underwent radical radiotherapy with the diagnosis of cervical squamous cell cancer. 11th National Radiation Oncology Congress, 23-27 April 2014, Antalya.
E41. Bayman E, Akçay M, Etiz D, Şaylısoy S. Clinical and dosimetric evaluation of early brachial plexopathy after radical radiotherapy in locally advanced head and neck cancer. 11th National Radiation Oncology Congress, 23-27 April 2014, Antalya.
E42. Bayman E, Akyazıcı E, Karaoğlanoğlu Ö. Is the completion of radiotherapy scheme a prognostic marker in adult patients with glioblastoma multiforme (GBM)? 11th National Radiation Oncology Congress, 23-27 April 2014, Antalya.
E43. Bayman E, Etiz D, Ak G, Akçay M. Comparison of early and late thoracic radiotherapy in limited stage small cell lung cancer. 11th National Radiation Oncology Congress, 23-27 April 2014, Antalya.
E44. E. Metcalfe, M. Sen, B. Sethugavas, K. Dyker, R. Speight, RJ Prestwich. Postoperative (chemo)radiotherapy in oral cavity squamous cell cancers: Treatment results and recurrence characteristics (Verbal). XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E45. A. Ozen, N. Coruhlu, H. Ozden, O. Demirkaya, K. Duruer, E. Metcalfe, D. Etiz. Comparison of the verification of IMRT and VMAT methods used in Whole Brain+SIB radiotherapy (Verbal). XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E46. DT Cosan, C. Öner, A. Soyocak, E. Metcalfe, M. Djamgoz. The effects of voltage-gated potassium channels on the oxidant system in breast cancer cells (Verbal). XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E47. A. Ozen, H. Ozden, O. Demirkaya, N. Coruhlu, E. Metcalfe, K. Duruer, D. Etiz. Whole brain radiotherapy (TBRT) + Simultaneous Integrated Boost (SEB) radiotherapy (Poster) in patients with single brain metastases. XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E48. E. Metcalfe, H. Ozden, N. Coruhlu, A. Ozen, D. Etiz. Dosimetric comparison of hybrid and double half VMAT techniques in radical radiotherapy of lung cancer: A case report (Poster). XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E49. M. Akçay, A. Özen, S. Erkasap, E. Metcalfe, D. Etiz. Our neoadjuvant treatment results in patients with rectal cancer. XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E50. E. Metcalfe, N. Coruhlu, H. Ozden, A. Ozen, D. Etiz. Dosimetric comparison of hybrid and double arc VMAT techniques in neoadjuvant radiotherapy of rectal cancer (Poster). XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E51. A. Ozen, O. Demirkaya, H. Ozden, N. Coruhlu, E. Metcalfe, K. Duruer, D. Etiz. Dosimetric comparison of two different techniques for whole brain radiotherapy (TBRT) + Simultaneous Integrated Boost (SEB) radiotherapy in patients with single brain metastases (Poster). XII. National Radiation Oncology Congress, 20-24 April 2016, Antalya.
E52. E. Metcalfe, O. Yazıcı, EK Kıraklı, A. Altınok, SA Arslan, R. İbrahimov, P. Altınok. Adjuvant approach in patients aged 70 years and older with head and neck carcinoma: TOG Head and Neck Cancer Group Study (Verbal). XIII. National Radiation Oncology Congress, 27 April-1 May 2018, KKTC (Turkish Journal of Oncology proceeding 2018; 33 (supp 1): 33.
E53. Altinok A, Gursel B, Ergen A, Alanyali S, Ozsaran Z, Ay A, Metcalfe E, Akmansu M, Tepetam H, Altinok P, Altmisdortoglu O, Serarslan A, Bese N. Postmastectomy radiotherapy decision in axillary lymph node negative breast cancer: TROD breast cancer study group (Verbal). XIII. National Radiation Oncology Congress, 27 April-1 May 2018, KKTC (Turkish Journal of Oncology proceeding 2018; 33 (supp 1): 20.
E54. E. Metcalfe, R. İbrahimov, M. Halaç, B. Günhan, A. Arifoğlu, N. Aslan, U. Abacıoğlu, A. Öber. Can GTV and SUV be a predictive factor before radiochemotherapy + brachytherapy in locally advanced cervical cancer? (virtual poster). Turkish Radiation Oncology Association Virtual Congress, 20-22 November 2020.
F. Art/design and cancer awareness events:
F1. Eskişehir Photography Art Association (EFSAD), group photography exhibition, 2016.
F2. Cancer week awareness project, “Don’t Lose Hope” group photography exhibition, with the contributions of Eskişehir Osmangazi University Rectorate and LÖSEV, 1-5 February 2016, Eskişehir (editor).
F3. Cancer week awareness project, National Radiation Oncology Congress, “Don’t Lose Hope” group photo exhibition, April 23, 2016.
G. Refereeing and Criticism in National and International Journals:
G1. Journal of Thoracic Oncology (2015 – )
G2. European Journal of Cancer Care (2016 – )
G3. Journal of Future Oncology (2017 – )
G4. Journal of Cancer Medicine (2018 – )
G5. Turkish Journal of Oncology (2019 – )
G6. Medicine Science / International Medical Journal (2019 – )
G7. Journal of Cancer Research and Therapeutics (2019 – )
H. National and international congresses and meetings, speeches and other duties:
H1. 9th National Laryngology Congress (speaker), 27-29 April 2017, Eskişehir Osmangazi University Congress and Culture Center, Eskişehir, Turkey.
H2. Symposium of Molecular Imaging with Ga-68 and current treatment approaches in prostate cancer (International speaker), 8th June 2017, Sady Pobedy, Odessa, Ukraine.
H3. Symposium of Diagnosis and Radiotherapy in Primary and metastatic brain tumors (International speaker), 20th July 2017, Sady Pobedy, Odessa, Ukraine.
H4. Bozlu Holding training seminars, “Time Management” (speaker), 06.03.2018, Mongeri Building, Şişli, Istanbul, Turkey.
H5. 4th Multidisciplinary Head and Neck Cancers Congress (panelist speaker), 08-11 March 2018, Antalya.
H6. XIII. National Radiation Oncology Congress (speaker), 27 April-1 May 2018, TRNC.
H7. The National Cogress of the Romanian Cancer Society Federation Fifth Edition (International speaker), 4-7 October 2018, Sinaia, Romania.
H8. 14th National Oncological Research Workshop (speaker), 14-18 November 2018, Antalya.
H9. 5th Multidisciplinary Head and Neck Cancers Congress (speaker), 07-10 March 2019, Antalya.
H10. International Symposium on Nutrition in Oncology Patients (chair/chairman), 12-13 April 2019, Istanbul, Turkey
H11. 23rd National Cancer Congress (speaker), 17-21 April 2019, Antalya.
H12. The Conferences of the Iaşi Regional Institute of Oncology (International speaker), 21-24 November 2019, Iaşi, Romania.
H13. 17th Uludağ Oncology Symposium (speaker), 13-14 December 2019, Bursa.
H14. 11. Demiroğlu Bilim University Oncology Day (Panelist speaker), 28 December 2019, Istanbul.
H15. Geriatric Cancer and Radiotherapy Symposium (organizer), 01 February 2020, Turkish Society of Radiation Oncology Meeting Hall, Istanbul.
H16. Geriatric Cancer and Radiotherapy Symposium (speaker), 01 February 2020, Turkish Society of Radiation Oncology Meeting Hall, Istanbul.
H17. 6th Multidisciplinary Head and Neck Cancers Congress (speaker), 05-08 March 2020, Antalya.
H18. 6th Multidisciplinary Head and Neck Cancers Congress (chairman), 05-08 March 2020, Antalya.
H19. IV. Geriatric Oncology Congress (speaker), 12-13 December 2020, virtual.
I. Refereeing and criticizing in national and international journals:
İ1. European Journal of Cancer Care, reviewer, manuscript ECC-2016-0093, 21 April 2016.
İ2. European Journal of Cancer Care, reviewer, manuscript ECC-2016-0109, 23 August 2016.
İ3. European Journal of Cancer Care, reviewer, manuscript ECC-2016-0443, 07 November 2016.
İ4. Future Oncology, reviewer, manuscript FON-2016-0467, 07 November 2016.
İ5. Turkish Journal of Oncology, reviewer, manuscript TOD-1598, 28 June 2017.
İ6. Future Oncology, reviewer, manuscript FON-2017-0706, 26 December 2017.
İ7. Cancer Medicine, reviewer, manuscript CAM4-2018-03-0540, 26 March 2018.
İ8. International Medical Journal, reviewer, 30 January 2019.
İ9. Turkish Journal of Oncology, reviewer, manuscript TOD-2024, 16 May 2019.
i10. Journal of Cancer Research and Therapeutics, reviewer, manuscript JCRT_440_19, 20 Sept 2019.
İ11. Journal of Immunology Research, reviewer, manuscript 8628540, 14 Oct 2020.
İ12. Turkish Journal of Oncology, reviewer, manuscript TOD-2303, 22 May 2020.
İ13. Turkish Journal of Oncology, reviewer, manuscript TOD-2566, 24 Nov 2020.
İ14. Grand Journal of Urology, reviewer, manuscript GJOU-54264, 07 Dec 2020.
İ15. Osmangazi Medical Journal, advisory board member, 2016- .
Number of citations made after associate professorship from J. Publications:
J1. doi: 10.7314/apjcp.2013.14.7.4223 – (4)
J2. doi:10.7314/apjcp.2013.14.9.5175 – (3)
J3. PMID: 24654465 – (30)
J4. doi: 10.1016/j.clon.2014.05.001 – (39)
J5. doi: 10.7314/apjcp.2014.15.15.6263. – (5)
J6. doi: 10.1016/j.clon.2015.03.005 – (21)
J7. doi: 10.1186/s12885-015-1867-8 – (36)
J8. doi: 10.5114/wo.2015.55876 – (6)
J9. doi: 10.5114/wo.2016.61569 – (6)
J10. doi: 10.1016/j.clon.2016.09:008 – (8)
J11. doi: 10.4103/0973-1482.183219 – (50)
J12. doi: 10.4103/0973-1482.203602 – (5)
J13. doi: 10.1007/s13187-018-1441-6 – (1)
h-index87i10-index75